Boca Pharmacal

Boca Pharmacal was a specialty pharmaceutical company focused on the development, marketing, and distribution of generic prescription drugs for the United States market. The company specialized in niche product categories, including oral solids, semi-solids, and liquids, with a particular emphasis on controlled substances and complex formulations that were difficult to manufacture. Founded in 1998 and headquartered in Florida, Boca Pharmacal built a robust portfolio of Abbreviated New Drug Applications (ANDAs) across various therapeutic areas such as pain management and respiratory health. In 2013, the company was acquired by Akorn for approximately $225 million to expand Akorn's generic drug pipeline and manufacturing footprint.